Atevirdine
![]() |
|
Names | |
---|---|
IUPAC name
[4-[3-(Ethylamino)pyridin-2-yl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone
|
|
Identifiers | |
136816-75-6 ![]() |
|
ChEMBL | ChEMBL280527 ![]() |
ChemSpider | 54835 ![]() |
Jmol 3D model | Interactive image |
PubChem | 60848 |
UNII | N24015WC6D ![]() |
|
|
|
|
Properties | |
C21H25N5O2 | |
Molar mass | 379.46 g/mol |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Ateviridine is non-nucleoside reverse transcriptase inhibitor that has been studied for the treatment of HIV.[1]
Synthesis
Preparation of the pyridylpiperazine moiety starts by aromatic displacement of chlorine from 2-Chloro-3-nitropyridine by piperazine to give 3. The secondary amine is then protected as its BOC derivative by reaction with Di-tert-butyl dicarbonate (Boc anhydride) to give 4. The nitro group is then reduced by catalytic hydrogenation. Reductive alkylation with acetaldehyde in the presence of lithium cyanoborohydride gives the corresponding N-ethyl derivative. The protecting group is then removed by reaction with TFA. Reaaction of the resulting amine with the imidazolide derivative of 5-Methoxy-3-indoleacetic acid affords the amide reverse transcriptase inhibitor, atevirdine.
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- Pages with reference errors
- Articles without KEGG source
- Pages using collapsible list with both background and text-align in titlestyle
- Chemical articles using a fixed chemical formula
- Abandoned drugs
- Carboxamides
- Indoles
- Non-nucleoside reverse transcriptase inhibitors
- Phenol ethers
- Piperazines
- Pyridines
- Antiinfective agent stubs